000 | 01700 a2200481 4500 | ||
---|---|---|---|
005 | 20250517041252.0 | ||
264 | 0 | _c20150806 | |
008 | 201508s 0 0 eng d | ||
022 | _a1121-2233 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLevi, M | |
245 | 0 | 0 |
_aSurveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012. _h[electronic resource] |
260 |
_bJournal of preventive medicine and hygiene _cDec 2014 |
||
300 |
_a145-51 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aChickenpox Vaccine _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aDiphtheria-Tetanus-Pertussis Vaccine _xtherapeutic use |
650 | 0 | 4 |
_aEdema _xchemically induced |
650 | 0 | 4 |
_aFever _xchemically induced |
650 | 0 | 4 | _aHaemophilus Vaccines |
650 | 0 | 4 |
_aHepatitis B Vaccines _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunization Schedule |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aItaly |
650 | 0 | 4 |
_aMeasles-Mumps-Rubella Vaccine _xtherapeutic use |
650 | 0 | 4 |
_aMeningococcal Infections _xprevention & control |
650 | 0 | 4 |
_aMeningococcal Vaccines _xadverse effects |
650 | 0 | 4 |
_aPoliovirus Vaccine, Inactivated _xtherapeutic use |
650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
650 | 0 | 4 |
_aSeizures, Febrile _xchemically induced |
650 | 0 | 4 |
_aVaccines, Combined _xtherapeutic use |
700 | 1 | _aDonzellini, M | |
700 | 1 | _aVarone, O | |
700 | 1 | _aSala, A | |
700 | 1 | _aBechini, A | |
700 | 1 | _aBoccalini, S | |
700 | 1 | _aBonanni, P | |
773 | 0 |
_tJournal of preventive medicine and hygiene _gvol. 55 _gno. 4 _gp. 145-51 |
|
999 |
_c25040057 _d25040057 |